Mesa Laboratories, Inc. (MLAB) To Go Ex-Dividend on February 28th

Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Monday, January 6th, Wall Street Journal reports. Shareholders of record on Friday, February 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, March 17th. This represents a $0.64 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Friday, February 28th.

Mesa Laboratories has a dividend payout ratio of 6.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Mesa Laboratories to earn $8.72 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.3%.

Mesa Laboratories Stock Down 0.9 %

NASDAQ:MLAB opened at $144.36 on Wednesday. Mesa Laboratories has a 1-year low of $83.68 and a 1-year high of $155.12. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $784.45 million, a price-to-earnings ratio of -3.12 and a beta of 0.83. The business’s fifty day moving average price is $139.37 and its 200 day moving average price is $129.09.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. On average, sell-side analysts forecast that Mesa Laboratories will post 8 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.